Ledger.Open graph →
SEC Form D · filed December 1, 2016

IMPEL NEUROPHARMA INC

Offering
$37.3M
Sold
$22.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Stewart D. Parker · Seattle, WADirectorJohn D. Hoekman · Seattle, WAExec · DirectorMahendra D. Shah · Seattle, WADirectorAaron D. Royston · Seattle, WADirectorPhilip Warth · San Clemente, CADirectorHGI Opportunity Select Fund V Managing Co., LLC · Norfolk, VAExec · DirectorJim D. Young · Seattle, WADirectorMahendra D. Shah · Seattle, WADirectorJohn Corpus · Denver, COExec · DirectorHGI US Property Fund IX Managing Co., LLC · Norfolk, VADirectorJim D. Young · Seattle, WADirectorMahendra D. Shah · Redwood City, CADirectorAaron D. Royston · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗